NCT03894618 2025-04-02SL-279252 (PD1-Fc-OX40L) in Subjects With Advanced Solid Tumors or LymphomasShattuck Labs, Inc.Phase 1 Completed49 enrolled 32 charts
NCT04439214 2021-04-06Testing Nivolumab as a Potential Targeted Treatment in Cancers With Mismatch Repair Deficiency (MATCH-Subprotocol Z1D)National Cancer Institute (NCI)Phase 2 Completed47 enrolled 10 charts